PAHC
PAHC
NASDAQ · Pharmaceuticals

Phibro Animal Health Corp-A

$54.89
+1.71 (+3.22%)
As of May 9, 1:28 AM ET ·
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 1 11%
Hold 4 44%
Sell 4 44%
Price Target
Analyst Price Target +96.2% upside
Low Target $71.95
Average Target $107.71
High Target $157.72
Current Price $54.89
Current
$54.89
Target
$107.71
$71.95 $107.71 avg $157.72
Scenario Analysis
Bear Case
$71.95
31.1%
Low target
Base Case
$107.71
+96.2%
Avg target
Bull Case
$157.72
+187.3%
High target
Risk/Reward
6.0x
Highly favorable
Price in Context
52-Week High
$60.08
-8.6% from high
52-Week Low
$19.00
+188.9% from low
50-Day SMA
$42.00
+30.7% vs SMA
200-Day SMA
$35.40
+55.1% vs SMA
RSI (14)
80.2
Overbought
Target vs 52W High
$107.71
+79.3% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $0.73
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%